Cargando…
Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study
Autores principales: | Treibel, Thomas A, Fontana, Marianna, Kozor, Rebecca, Reant, Patricia, Espinosa, Maria A, Castelletti, Silvia, Bulluck, Heerajnarain, Bhuva, Anish N, White, Steven K, Herrey, Anna S, Manisty, Charlotte, Moon, James C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032105/ http://dx.doi.org/10.1186/1532-429X-18-S1-O37 |
Ejemplares similares
-
T1 mapping in severe aortic stenosis: insights into LV remodeling
por: Treibel, Thomas A, et al.
Publicado: (2015) -
Hematocrit, iron and HDL-cholesterol explain 90% of variation in native blood T1
por: Rosmini, Stefania, et al.
Publicado: (2016) -
Native myocardial T1 and ECV with age and gender developing normal reference ranges - a 94 healthy volunteer study
por: Rosmini, Stefania, et al.
Publicado: (2016) -
Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis
por: Treibel, Thomas A., et al.
Publicado: (2018) -
LGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
por: Fontana, Marianna, et al.
Publicado: (2015)